DexCom, Inc. (DXCM)
68.10
-2.59
(-3.66%)
USD |
NASDAQ |
Mar 06, 16:00
68.10
0.00 (0.00%)
After-Hours: 20:00
DexCom SG&A Expense (TTM) : 1.291B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 12.33B |
| Insulet Corp. | 1.165B |
| BioLife Solutions, Inc. | 42.83M |
| Krystal Biotech, Inc. | 146.91M |
| Boston Scientific Corp. | 6.888B |